Table of Contents Product Category Diabetes GLP-1 Receptor Agonist Generic Name or Biosimilar No Active Ingredient Liraglutide Prescription Status Prescription-only Targeted Conditions Victoza is approved to treat: Type 2 Diabetes Mellitus (T2DM), as an adjunct to diet and exercise Cardiovascular risk reduction in adults with T2DM and established cardiovascular disease Off-Label Usage While not formally approved, Victoza has also been prescribed off-label for: Weight loss in individuals with obesity or overweight (in lower doses than Saxenda, which contains the same ingredient at higher doses) Polycystic Ovary Syndrome (PCOS) with metabolic dysfunction Nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH) All off-label use must be supervised by a licensed healthcare provider
and Victoza Dosing: How Much Should You Take
For most patients, minimal preparation is required before receiving a Vitamin B12 shot
Free Radic Biol Med 150:136147 Mahmoud AM, Germoush MO, Alotaibi MF, Hussein OE (2017) Possible involvement of Nrf2 and PPAR up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity
Beneficial effects of polyphenols on cardiovascular disease
It is a prescription metabolic medication with a mechanism of action that has nothing in common with the substances that standard panels target